NASDAQ: KYTX
Kyverna Therapeutics Inc Stock Ownership - Who owns Kyverna Therapeutics?

Insider buying vs selling

Have Kyverna Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Beth C. SeidenbergDirector2025-12-18133,333$7.50
$1,000.00kBuy
Westlake Biopartners Opportunity Fund I LP10% Owner2025-12-18133,333$7.50
$1,000.00kBuy
Karen Marie WalkerChief Technology Officer2025-12-1523,998$4.83
$115.91kBuy
Karen Marie WalkerChief Technology Officer2025-12-1523,998$12.20
$292.78kSell

1 of 1

KYTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KYTX insiders and whales buy or sell their stock.

KYTX Shareholders

What type of owners hold Kyverna Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vida Ventures LLC7.90%4,777,060$42.37MInsider
Fred E. Cohen7.51%4,540,558$40.27MInsider
Gordonmd Global Investments LP7.27%4,391,818$38.96MInstitution
Gilead Sciences Inc6.83%4,126,119$36.60MInsider
Gilead Sciences Inc6.83%4,126,119$36.60MInstitution
Beth C. Seidenberg6.29%3,804,574$33.75MInsider
Westlake Biopartners Opportunity Fund I LP6.27%3,787,940$33.60MInsider
Northpond Ventures III GP LLC5.39%3,255,426$28.88MInsider
Bain Capital Life Sciences Investors LLC5.23%3,163,868$28.06MInsider
Bain Capital Life Sciences Investors LLC5.15%3,110,000$27.59MInstitution

1 of 3

KYTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KYTX53.71%46.29%Net Buying
RIGL39.34%60.66%Net SellingNet Selling
AGMB0.00%0.09%
TECX26.30%73.70%Net BuyingNet Selling
ALLO66.72%31.96%Net SellingNet Selling

Kyverna Therapeutics Stock Ownership FAQ

Who owns Kyverna Therapeutics?

Kyverna Therapeutics (NASDAQ: KYTX) is owned by 56.47% institutional shareholders, 48.68% Kyverna Therapeutics insiders, and 0.00% retail investors. Vida Ventures LLC is the largest individual Kyverna Therapeutics shareholder, owning 4.78M shares representing 7.90% of the company. Vida Ventures LLC's Kyverna Therapeutics shares are currently valued at $42.37M.

If you're new to stock investing, here's how to buy Kyverna Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.